QA: Lexicon Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001062822_2021_Lexicon_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001062822, Lexicon Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 157,719,000
1 IntangibleAssetsNetIncludingGoodwill 44,543,000
2 PropertyPlantAndEquipmentNet 295,000
3 remainder_Assets 1,231,000
4 LiabilitiesCurrent 46,806,000
5 LiabilitiesNoncurrent 611,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,733,943
8 SellingGeneralAndAdministrativeExpense 47,297,479
9 ResearchAndDevelopmentExpense 139,951,751
10 remainder_Expenses 23,871,108
11 remainder_Revenues 318,168,870
12 remainder_NetIncome 13,504,920
13 remainder_ComprehensiveNetIncome -172,515
  yvar yval
0 Assets 203,788,000
1 Liabilities 47,417,000
2 Expenses 212,854,281
3 Revenues 318,168,870
4 StockholdersEquity 156,371,000
5 NetIncome 118,819,509
6 ComprehensiveNetIncome 118,733,252
7 BaseVar 397,952,793
8 EconomicCapitalRatiobeforeLimitedLiability 3.66
9 EconomicCapitalRatio 4.14

Edgar->Model Mapping

Feature Distribution

Change over Time